肯尼亚部分机构解剖病理与检验医学诊断服务及基础设施分析
该研究通过两项问卷调查了2022年6月至8月肯尼亚18家实验室的解剖病理(AP)和临床病理(CP)服务能力。结果显示基础AP和CP服务较常见,但分子检测、细胞遗传学和流式细胞术等高级诊断手段普遍缺乏。
要点
- 18家实验室中5家提供AP服务,17家提供CP服务,4家同时提供两者。
- 所有5家AP机构均提供细胞病理、尸检和血液病理服务,但无分子检测能力。
- CP机构中 rapid diagnostic/point-of-care检测、生化、微生物和血液/凝血服务较普遍,细胞遗传学和流式细胞术仅4家(24%)可用。
核心结论
- 在该肯尼亚机构样本中,基础AP和CP服务较常提供,而高级诊断方法则属例外。
研究设计与样本
- 由主题专家设计两项分别评估AP和CP的独立问卷,于2022年6月至8月通过美国临床病理学会邮件列表对肯尼亚医院和实验室病理服务人员进行调查,分析18家独特实验室的回复。
主要发现
- 5家机构提供AP服务,17家提供CP服务,4家同时提供AP和CP服务。
- 所有5家AP机构均提供细胞病理、尸检和血液病理服务;4家(80%)提供大切除标本切缘病理服务,2家(40%)提供小活检服务。
- 无机构具备分子检测能力。
- 17家CP机构中,14家(82%)能进行快速诊断和/或床旁检测,13家(76%)能进行生化、微生物、血液和/或凝血检测;细胞遗传学和流式细胞术一般不可用(4家,24%)。
关键数值与推荐
- AP服务:细胞病理、尸检、血液病理在所有5家AP机构可用;大切除标本切缘病理4家(80%),小活检2家(40%)。
- CP服务:快速诊断和/或床旁检测14家(82%),生化13家(76%),微生物13家(76%),血液和/或凝血13家(76%),细胞遗传学和流式细胞术4家(24%)。
临床怎么用
- 提示肯尼亚样本机构中基础病理和检验服务可及,但高级诊断能力有限,可作为战略投资优化卫生系统的参考。
局限性
- 样本量小(18家实验室),仅代表回复调查的机构,可能无法反映肯尼亚全国情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: There is a paucity of data regarding the anatomic and clinical pathology capabilities at hospitals and laboratories across much of Africa, including in Kenya. We aimed to sample institutions in Kenya to identify the available pathology and laboratory diagnostic services. METHODS: Subject matter experts developed 2 individual surveys assessing anatomic pathology (AP) and clinical pathology (CP), respectively. The surveys were administered to individuals involved in pathology services at hospitals and laboratories across Kenya between June and August 2022 using the American Society for Clinical Pathology email listserv. RESULTS: Responses from 18 unique laboratories in Kenya were analyzed. Five sites provided AP services, while 17 provided CP services; 4 sites provided both AP and CP services. Cytopathology, autopsy services, and hematopathology services were available at all 5 sites that performed AP; 4 provided surgical pathology services for large resections with margins (80%); and 2 provided services for small biopsies (40%). No location had molecular testing capabilities. Among the 17 sites that provided CP services, most had the capability to perform rapid diagnostic and/or point-of-care testing (n = 14, 82%), chemistry (n = 13, 76%), microbiology (n = 13, 76%), and hematology and/or coagulation (n = 13, 76%). However, cytogenetics and flow cytometry were generally not available (n = 4, 24%). CONCLUSIONS: These findings demonstrate that, among this sample of institutions in Kenya, basic AP and CP services were frequently available. Conversely, advanced diagnostic modalities were the exception. Strategic investment to improve this capacity could contribute to optimization of the health care system in Kenya.
引用
- McKenzie N, Jacobs JW, Milner DA, et al. Analysis of anatomic pathology and laboratory medicine diagnostic services and infrastructure available at a sample of institutions in Kenya. Am J Clin Pathol. 2025. PMID: 40734656. doi:10.1093/ajcp/aqaf021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。